一、國科會與與法國國家癌症研究院（INCa）簽署之合作備忘錄，國科會補助我國研究人員參與法方PLBIO方案，合作領域為癌症相關（得含認知科學）之原創知識或前瞻技術研究；惟不含轉譯學研究、臨床實驗、流行病與公共衛生研究等三類主題。

二、徵案範圍 （Scope of the call）：
The “Cancer Biology and Basic Sciences” call for basic research proposals is opened to all areas of basic research and scientific fields involved in the fight against cancer aimed at acquiring new knowledge, and developing new tools and opening new therapeutic perspectives.
Multi-disciplinary projects, which have contributions from fields other than biology, are encouraged. The biology part of the project must be significant and relevant.
Note:
Are considered out of scope of this call for proposals:
■Fundamental research projects which are not related to cancer;
■Projects focusing on translational research (call for proposals “Translational research in cancerology, PRT-K 2025–2026”);
■Clinical trials (call for proposals “Programme for Hospital Clinical Cancer Research”, PHRC 2025–2026);
■Projects on human and social sciences, and epidemiology (call for proposals “Human and Social Sciences, Epidemiology and Public Health”, SHSESP 2026);
■Projects which are eligible for the calls for proposals launched by Inserm.
A same letter of intent/full application cannot be submitted simultaneously to several INCa calls for proposals;
A same letter of intent/full application cannot be submitted to other calls until the result of the non-selection of this letter of intent/full application has been notified by INCa to the coordinator.
Recommendations:
This call for proposals is highly competitive; it is strongly recommended to principal investigators to respect the objectives of the call and to propose projects that meet the following criteria:
■Projects with scientific relevance to cancer;
■Projects which are original in their study subject and approaches;
■Mechanistic studies to answer the scientific questions;
■Projects relying on a strong methodological strategy, including alternative approaches and statistics/power calculation;
■Projects hypothesis-driven and relying on preliminary data.

三、申請方式：
計畫徵求分「意向書」及「完整計畫書」兩階段申請作業，敬請詳閱INCa公告文件說明。
(一）第一階段:由法方計畫主持人偕同臺方計畫主持人至INCa線上申辦系統提交意向書。
(二) 第二階段:經INCa初審後，國科會將邀請通過第一階段意向書審查之臺方計畫主持人，向國科會研提第二階段完整計畫書；法方計畫主持人則向INCa研提第二階段完整計畫書，相關作業規定依INCa公告為準（如附件）。

四、暫定計畫執行日期自2027年1月1日起（Project duration 請參考INCa公告文件說明）。

五、申請時程：
第一階段徵件由INCa受理至11月3日下午4點截止（巴黎時間-依INCa官網公告為準）

六、徵求細節敬請詳閱下列資訊：
(一)國科會公函
(二)INCa公告文件
(三)INCa計畫徵求公告網頁:https://www.cancer.fr/professionnels-de-la-recherche/appels-a-projets-et-a-candidatures/nos-appels-a-projets/plbio2026

七、本案聯絡人：
(一)國科會科國處
    ■聯絡人：廖亞旋科員
    ■電話：02-2737-7557 
    ■Email: yhliao1@nstc.gov.tw
(二)國科會資訊系統服務專線：0800-212-058
(三)法國INCa窗口：
    ■For any scientific concern, please contact: Marion PIEDFER, Scientific Officer, Research & Innovation Division – Biology, Transfer and Innovations department: mpiedfer@institutcancer.fr
    ■For administrative concern or technical issues, please contact: assistanceprojets@institutcancer.fr
(四)研發處計管組
    ■蘇暐珍：分機35010
    ■電子郵件：weicsu@mx.nthu.edu.tw